|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: Didac Mauricio , Nuria Alonso (Department of Endocrinology and Nutrition, University Hospital Germans Trias i Pujol Badalona; Faculty of Medicine, Auonomous University of Barcelona, Spain)Publisher: Elsevier Science & Technology Imprint: Academic Press Inc ISBN: 9780323884266ISBN 10: 0323884261 Pages: 300 Publication Date: 01 February 2023 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Forthcoming Availability: Not yet available ![]() This item is yet to be released. You can pre-order this item and we will dispatch it to you upon its release. Table of ContentsIntroductory chapters 1. Overview on chronic complications of diabetes mellitus 2. Epidemiology of chronic complications: A global perspective 3. Molecular mechanisms involved in hyperglycemia-induced cellular damage 4. Vascular calcification in diabetes mellitus: Molecular mechanisms and clinical implications Classical complications 5. Pathogenesis of diabetic atherosclerotic cardiovascular disease 6. Chronic kidney disease in diabetes: Current concepts 7. Diabetic retinopathy: New insights 8. Macular edema: A fearful complication of diabetic eye disease 9. The eye as a mirror of neuronal impairment 10. Diabetic neuropathy: Current issues in diagnosis and prevention Non-classical complications 11. Pathophysiological and clinical aspects of non-classical targets of microangiopathy 12. Diabetic bone disease: Metabolic and microvascular damage 13. Non-alcoholic fatty liver disease: What's before and what are the consequences 14. The diabetic lung 15. Diabetic cardiomyopathy: Pathogenetic mechanisms and clinical consequences 16. Diabetes-related cognitive impairment and dementia in diabetes 17. Cancer in diabetes: Who is who? Outlook in management issues 18. Metabolic memory: what is in it? 19. HbA1c, or glucose variability for causing diabetic complications? 20. Current perspectives on prevention of cardiovascular disease in diabetes 21. Prevention and management of chronic kidney disease in diabetes 22. Heart failure in diabetes: Current clinical management 23. Diabetic eye disease: Novel therapeutic strategies 24. Diabetic foot disease: Recent therapeutic progressReviewsAuthor InformationDidac Mauricio, MD, PhD, is currently Chief Physician and acting Head of the Department of Endocrinology & Nutrition, University Hospital Germans Trias i Pujol, affiliated with the Autonomous University in Barcelona. After receiving his medical degree with honors from the University of Barcelona, Dr. Mauricio completed his fellowship in Endocrinology & Nutrition at Hospital de Sant Pau, Autonomous University of Barcelona, Spain. In 1993, he presented his PhD thesis at the School of Medicine, Autonomous University of Barcelona. From 1994 to 1995, he was a post-doctoral research fellow for Professor J. Nerup at the Steno Diabetes Center & Hagedorn Research Institute in Gentofte, Denmark. Dr. Mauricio has delivered numerous invited lectures at major medical conferences, and has been principal investigator of several research projects funded by national and international agencies. He keeps a strong interest in current clinical issues in diabetes management, including randomized clinical trials, and is currently involved in projects dealing with the study of immune, metabolic, and genetic markers of autoimmune diabetes, and diabetic micro- and macroangiopathic complications. Dr. Mauricio has published more than 130 peer-reviewed articles and has contributed to multiple books, and is currently the Editor-in Chief of Endocrinologia y Nutricion, the official journal of the Spanish Society of Endocrinology & Nutrition. Nuria Alonso, MD PhD is a staff endocrinologist and head of the diabetes section at the Department of Endocrinology & Nutrition at University Hospital Germans Trias i Pujol Badalona, Spain. She is Assistant Professor at the Faculty of Medicine, Autonomous University of Barcelona. N. Alonso has published a total of 66 scientific articles in indexed journals. Currently, her clinical activity is mainly focused on those conditions that are associated with an increased risk of atheromatous CV disease, with special focus on diabetes mellitus (type 1 and type 2) and familial hypercholesterolemia. In the clinical research field, she is focused on the study of subclinical atheromatosis in patients with diabetes, as well as its association with microvascular complications. In recent years, her scientific activity has also developed on the study of lipotoxicity in diabetes and its association with ectopic fat deposition. She has been principal investigator of several research projects funded by national and international agencies. Tab Content 6Author Website:Countries AvailableAll regions |